文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

何时为止?输血量与生存几率的关系

When is enough enough? Odds of survival by unit transfused.
PubMed 文献 · J Trauma Acute Care Surg · 2022-11-10
一句话结论每增加1单位平衡输血死亡率上升,超过16 U PRBC/4小时生存几率低于死亡几率,超过36 U PRBC/4小时生存率接近零,作者建议考虑停止复苏。

该回顾性研究纳入2018年1月至2021年12月一家一级创伤中心296例就诊时接受大量输血的患者中的207例(中位年龄32岁,中位损伤严重度评分25,67%为穿透伤),记录最初4小时内PRBC、FFP和血小板用量,按PRBC用量分为输血组(2-9 U)、大量输血组(10-19 U)和超大量输血组(≥20 U)。总死亡率29%(61/207)。PRBC 11 U时生存几率等于死亡几率(OR 0.95,95%CI 0.50-1.79);超过16 U PRBC时死亡几率超过生存几率(OR 0.36,95%CI 0.16-0.82);超过36 U PRBC时生存率接近零(OR 0.09,95%CI 0.00-0.56)。亚组死亡率随输血量增加而升高(输血组16% vs 大量输血组36%,p=0.003;大量输血组36% vs 超大量输血组67%,p=0.006)。作者认为超过16 U PRBC/4小时应视为英雄式努力,超过36 U PRBC/4小时接近徒劳,可考虑停止复苏,尤其在未实现止血或血源有限时。

要点

  • PRBC 11 U/4小时时生存几率与死亡几率相等(OR 0.95,95%CI 0.50-1.79)。
  • 超过16 U PRBC/4小时死亡几率超过生存几率(OR 0.36,95%CI 0.16-0.82)。
  • 超过36 U PRBC/4小时生存率接近零(OR 0.09,95%CI 0.00-0.56),作者建议可考虑停止复苏。
  • 亚组死亡率:输血组16% vs 大量输血组36%(p=0.003);大量输血组36% vs 超大量输血组67%(p=0.006)。
  • 作者认为超过16 U PRBC/4小时视为英雄式努力,超过36 U PRBC/4小时接近徒劳,尤其未止血或血源有限时。

适用人群与场景

  • 就诊时接受大量输血的一级创伤中心创伤患者,中位年龄32岁,中位损伤严重度评分25,67%为穿透伤。
  • 排除标准:在急诊科死亡、到院时死亡、接受<2 U PRBC或FFP、或PRBC/FFP>2:1的患者。

诊断标准与关键阈值

  • 按最初4小时PRBC用量分组:输血组2-9 U,大量输血组10-19 U,超大量输血组≥20 U。
  • PRBC 11 U/4小时为生存几率等于死亡几率的平衡点(OR 0.95,95%CI 0.50-1.79)。

红旗征与不能漏的情况

  • 超过16 U PRBC/4小时死亡几率超过生存几率(OR 0.36,95%CI 0.16-0.82),应视为英雄式努力。
  • 超过36 U PRBC/4小时生存率接近零(OR 0.09,95%CI 0.00-0.56),作者建议可考虑停止复苏,尤其在未实现止血或血源有限时。

研究设计与关键结果

  • 回顾性研究,207例就诊时接受大量输血的创伤患者,来自一家一级创伤中心,2018年1月至2021年12月。
  • 总死亡率29%(61/207)。
  • PRBC 11 U/4小时时生存几率等于死亡几率(OR 0.95,95%CI 0.50-1.79)。
  • 超过16 U PRBC/4小时死亡几率超过生存几率(OR 0.36,95%CI 0.16-0.82)。
  • 超过36 U PRBC/4小时生存率接近零(OR 0.09,95%CI 0.00-0.56)。
  • 亚组死亡率:输血组16% vs 大量输血组36%(p=0.003);大量输血组36% vs 超大量输血组67%(p=0.006)。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 证据等级:预后与流行病学;Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为超过16 U PRBC/4小时应视为英雄式努力,超过36 U PRBC/4小时接近徒劳。
  • 作者建议超过36 U PRBC/4小时可考虑停止复苏,尤其在未实现止血或血源有限时;极端例外仍可能存活。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Balanced transfusion is lifesaving for hemorrhagic shock. The American Red Cross critical blood shortage in 2022 threatened the immediate availability of blood. To eliminate waste, we reviewed the utility of transfusions per unit to define expected mortality at various levels of balanced transfusion.

METHODS: A retrospective study of 296 patients receiving massive transfusion on presentation at a level 1 trauma center was performed from January 2018 to December 2021. Units of packed red blood cells (PRBCs), fresh frozen plasma (FFP), and platelets received in the first 4 hours were recorded. Patients were excluded if they died in the emergency department, died on arrival, received <2 U PRBCs or FFP, or received PRBC/FFP >2:1. Primary outcomes were mortality and odds of survival to discharge. Subgroups were defined as transfused if receiving 2 to 9 U PRBCs, massive transfusion for 10 to 19 U PRBCs, and ultramassive transfusion for ≥20 U PRBCs.

RESULTS: A total of 207 patients were included (median age, 32 years; median Injury Severity Score, 25; 67% with penetrating mechanism). Mortality was 29% (61 of 207 patients). Odds of survival is equal to odds of mortality at 11 U PRBCs (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.50-1.79). Beyond 16 U PRBCs, odds of mortality exceed survival (OR, 0.36; 95% CI, 0.16-0.82). Survival approaches zero >36 U PRBCs (OR, 0.09; 95% CI, 0.00-0.56). Subgroup mortality rates increased with unit transfused (16% transfused vs. 36% massive transfusion, p = 0.003; 36% massive transfusion vs. 67% ultramassive transfusion, p = 0.006).

CONCLUSION: Mortality increases with each unit balanced transfusion. Surgeons should view efforts heroic beyond 16 U PRBCs/4 hours and near futile beyond 36 U PRBCs/4 hours. While extreme outliers can survive, consider cessation of resuscitation beyond 36 U PRBCs. This is especially true if hemostasis has not been achieved or blood supplies are limited.

LEVEL OF EVIDENCE: Prognostic and Epidemiologic; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Loudon AM, Rushing AP, Hue JJ, et al. When is enough enough? Odds of survival by unit transfused. J Trauma Acute Care Surg. 2022. PMID: 36694331. doi:10.1097/TA.0000000000003835

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。